Omada Health

Q2 FY2026 EarningsQ2 FY26 results significantly beat consensus across the board: revenue of $87.8M vs. $80.1M expected, and gross margin of 72.6% vs. 68.6% expected. The company achieved positive GAAP net income of $5.3M ($0.08 per diluted share), a major surprise against the expected loss of $1.2M and EPS loss of $0.02. This outperformance was primarily driven by a 45% YoY increase in total members and significant Care Team efficiency gains. While no formal forward guidance was provided in the text, the momentum in member enrollment and margin expansion suggests a strong trajectory for the remainder of FY26.